Healthcare data

Clinical concept normalization, the process of linking free-text mentions with clinical concepts from a standardized terminology, is essential for enabling analysis of healthcare data, especially Electronic Health Records (EHR), for research. However, the task presents significant challenges due to the extensive variation and ambiguity in medical text, especially in multilingual settings. In our technical report, we evaluated the LynxCare system for concept normalization and compared it against two popular open-source systems. Download full technical research paper by completing the form on the right.

On January 30, LynxCare had the honor of participating in Dedalus's annual D4Evolution conference in Paris, themed "Innovons et accélérons ensemble la e-santé" ("Let's Innovate and Accelerate E-Health Together"). This event brought together a vibrant community of clients, partners, and experts to discuss the future of digital health.

We are thrilled to announce our partnership with Dedalus, transforming Real-World Data access in Europe. By combining LynxCare’s disease-specific Natural Language Processing capabilities and Dedalus’ healthcare expertise, we're set to facilitate the access and curating of fresh clinical data directly from the hospital information system. This collaboration empowers healthcare institutions and life sciences companies with accurate patient insights for more informed clinical decisions and research.

From 17-18 October, we are attending Frontiers Health 2024 in Berlin, one of the most renowned events in digital health innovation. Jeanne Kehren (CEO) will be presenting LynxCare during the start-up and scale-up discovery session. 

We successfully completed a pilot project in mental health in collaboration with Obasi, and supported by Johnson & Johnson.

We are proud to share that we have been recognized as one of the World's Best Digital Health Companies by Newsweek and Statista!

LynxCare appoints Jeanne Kehren as new Chief Executive Officer. She succeeds Georges De Feu, LynxCare’s visionary founder, who stepped aside from his position as CEO.

As Heart Failure Awareness Week comes to a close, we wanted to take a moment to reflect on the insights shared throughout the week. We've delved into various aspects of heart failure management, from the promise of AI-NLP technology to bridging the gaps in heart failure research.

LynxCare is excited to announce the appointment of Laurent van Lerberghe, former Chief Strategy Officer at Sanofi, as Investor and Board Advisor. LynxCare is a scale-up company in Clinical Artificial Intelligence part of the CB Insights Global Digital Health 150, supported by renowned VC investors MTIP (CH), Elaia (FR), B2Ventures (CH-DE) and Heran partners (BE).